CKD732: Clinical Trials

2 trials of CKD732, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow CKD732: new trials by email Literature Review of CKD732 trials Research Report on CKD732

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of Obesity
ZGN-440, ZGN-440 sterile diluent - Obesity
Phase 1CompletedZafgen, Inc.252011-12-012012-07-18
Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers
ZGN-433, Normal Saline - Obesity
Phase 1CompletedZafgen, Inc.252011-06-012011-12-30

Conditions studied

Obesity (2)  ·  Overweight (2)

Sponsors

Zafgen, Inc. (2)

Countries

Australia (2)

Top investigators

J K Marjason, MD (2)